Public and private pharmaceutical spending as determinants of health outcomes in Canada

Health Economics
P Y CrémieuxKen Potvin

Abstract

Canadian per capita drug expenditures increased markedly in recent years and have become center stage in the debate on health care cost containment. To inform public policy, these costs must be compared with the benefits provided by these drugs. This paper measures the statistical relationship between drug spending in Canadian provinces and overall health outcomes. The analysis relies on more homogenous data and includes a more complete set of controls for confounding factors than previous studies. Results show a strong statistical relationship between drug spending and health outcomes, especially for infant mortality and life expectancy at 65. This relationship is almost always stronger for private drug spending than for public drug spending. The analysis further indicates that substantially better health outcomes are observed in provinces where higher drug spending occurs. Simulations show that if all provinces increased per capita drug spending to the levels observed in the two provinces with the highest spending level, an average of 584 fewer infant deaths per year and over 6 months of increased life expectancy at birth would result.

References

Sep 1, 1978·Journal of Epidemiology and Community Health·A L CochraneF Moore
Feb 1, 1992·BMJ : British Medical Journal·D P Southall, M P Samuels
Jul 1, 1993·Journal of Gerontology·M WolfsonM Tomiak
Jan 1, 1993·Health Affairs·J P Newhouse
Jun 8, 1991·Journal of Health Economics·U G Gerdtham, B Jönsson
Apr 8, 1992·Journal of Health Economics·U G GerdthamB Jönsson
Jul 7, 1992·Journal of Health Economics·T Hitiris, J Posnett
May 10, 1987·Journal of Health Economics·D ParkinB Yule
Nov 2, 1999·Health Economics·P Y CrémieuxC Pilon

❮ Previous
Next ❯

Citations

Jan 24, 2006·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·John Nixon, Philippe Ulmann
Aug 13, 2009·Expert Review of Pharmacoeconomics & Outcomes Research·Paul GrootendorstMinsup Shim
Dec 1, 2007·Health Economics·Jesús ClementeAntonio Montañés
Feb 15, 2013·Health Economics·Massimiliano Piacenza, Gilberto Turati
Apr 24, 2015·Health Economics·Thierry NianogoWeiwei Chen
Jan 24, 2006·Social Science & Medicine·Craig R MittonJennifer Gibson
Jul 15, 2006·Inquiry : a Journal of Medical Care Organization, Provision and Financing·Frank R Lichtenberg
Feb 15, 2008·The Annals of Pharmacotherapy·Li LiuJon C Schommer
Sep 21, 2017·International Journal of Environmental Research and Public Health·Qilong CaoXueting Niu
Aug 23, 2017·Applied Health Economics and Health Policy·Davide GolinelliGabriele Messina
Mar 6, 2007·PharmacoEconomics·Pierre-Yves CrémieuxPatrick Petit
Oct 31, 2008·Health Economics·G Emmanuel Guindon, Paul Contoyannis
Nov 24, 2018·Globalization and Health·Mohammad Mafizur RahmanMaisha Rahman
Sep 8, 2019·International Journal of Health Economics and Management·Devdatta Ray, Mikael Linden
Feb 9, 2013·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Hiroaki KakiharaXinxin Ma
Jul 7, 2019·International Journal of Environmental Research and Public Health·Pedro Antonio Martín CervantesSalvador Cruz Rambaud
Jan 5, 2017·International Journal of Health Economics and Management·Ruolz Ariste, Livio Di Matteo
Jan 13, 2017·International Journal for Equity in Health·Błażej Łyszczarz
Nov 28, 2009·Expert Review of Pharmacoeconomics & Outcomes Research·Frank R Lichtenberg
Nov 24, 2016·International Journal of Health Economics and Management·Emmanuelle Piérard
Nov 25, 2020·International Journal of Environmental Research and Public Health·Pedro Antonio Martín CervantesSalvador Cruz Rambaud

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.